Catalyst Wire Dossier Catalyst Wire Dossier

Estradiol Transdermal System (Alternate Second Generation)

estradiol transdermal system · Mylan Pharmaceuticals Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Estradiol Transdermal System (Alternate Second Generation), covering 2008-04-01 to 2008-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System [Phase 1]

See pricing